Работайте офлайн с приложением Player FM !
Deep Dive into AbbVie's Orilissa for Endometriosis- Just the Beginning Pt 1
Manage episode 355005149 series 3123487
Disclaimer- The stories you are about to hear are the personal experiences of each individual and the views expressed by guests are their own. Please listen with discretion as this series contains mature content that could possibly be triggering to some individuals. Mention of depression, suicidal ideation, medical trauma, sexual assault, disorder eating and other sensitive topics may come up. Please listen at your own discretion and remember this podcast is never meant to be taken as medical advice.
Let's take a look at the state of AbbVie before Orilissa hit the market and where the motives for this "ground breaking" drug for the treatment of endometriosis pain. This episode is packed full with researched- backed information that starts to paint the picture of why endometriosis is treated the way it is in the medical community. And how that’s changed since the drug Orilissa came on the market. The first FDA approved drug for the treatment of endo pain since Lupron. Which was approved for use with endometriosis in 2001. This is just the beginning of our deep dive into Orilissa. If you've been on this drug and would like to share your experience with it please email the show at bestworstclub@yahoo.com.
Sources mentioned:
Lupron FDA approval- https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203696Orig1s000SumR.pdf
Humira Patent- https://blog.petrieflom.law.harvard.edu/2021/01/06/abbvie-humira-antitrust-patent-thicket/
Abbvie expects 1 billion- https://www.reuters.com/article/us-abbvie-orilissa/abbvie-prices-new-endometriosis-drug-at-10000-a-year-idUSKBN1KE2O3
Suicide- https://www.rxabbvie.com/pdf/orilissa_pi.pdf
If you are interested in being on Best Worst Club podcast you can use this link to set up a time to record with host, Mariah! Currently interviews for the series It’s Not Just A Bad Period are being scheduled. But if there is something specific related to endometriosis that you would like to talk about email the show at bestworstclub@yahoo.com
Hosted by Mariah Battaglia- Come say Hi and let me know if you're interested in attending Best Worst Club Events. Join the Club and our private group chat on Instagram here @EndoDoula You can support the podcast by leaving an honest review and sharing on social media, don't forget to tag @BestWorstClub
--- Support this podcast: https://podcasters.spotify.com/pod/show/bwclub/support18 эпизодов
Manage episode 355005149 series 3123487
Disclaimer- The stories you are about to hear are the personal experiences of each individual and the views expressed by guests are their own. Please listen with discretion as this series contains mature content that could possibly be triggering to some individuals. Mention of depression, suicidal ideation, medical trauma, sexual assault, disorder eating and other sensitive topics may come up. Please listen at your own discretion and remember this podcast is never meant to be taken as medical advice.
Let's take a look at the state of AbbVie before Orilissa hit the market and where the motives for this "ground breaking" drug for the treatment of endometriosis pain. This episode is packed full with researched- backed information that starts to paint the picture of why endometriosis is treated the way it is in the medical community. And how that’s changed since the drug Orilissa came on the market. The first FDA approved drug for the treatment of endo pain since Lupron. Which was approved for use with endometriosis in 2001. This is just the beginning of our deep dive into Orilissa. If you've been on this drug and would like to share your experience with it please email the show at bestworstclub@yahoo.com.
Sources mentioned:
Lupron FDA approval- https://www.accessdata.fda.gov/drugsatfda_docs/nda/2012/203696Orig1s000SumR.pdf
Humira Patent- https://blog.petrieflom.law.harvard.edu/2021/01/06/abbvie-humira-antitrust-patent-thicket/
Abbvie expects 1 billion- https://www.reuters.com/article/us-abbvie-orilissa/abbvie-prices-new-endometriosis-drug-at-10000-a-year-idUSKBN1KE2O3
Suicide- https://www.rxabbvie.com/pdf/orilissa_pi.pdf
If you are interested in being on Best Worst Club podcast you can use this link to set up a time to record with host, Mariah! Currently interviews for the series It’s Not Just A Bad Period are being scheduled. But if there is something specific related to endometriosis that you would like to talk about email the show at bestworstclub@yahoo.com
Hosted by Mariah Battaglia- Come say Hi and let me know if you're interested in attending Best Worst Club Events. Join the Club and our private group chat on Instagram here @EndoDoula You can support the podcast by leaving an honest review and sharing on social media, don't forget to tag @BestWorstClub
--- Support this podcast: https://podcasters.spotify.com/pod/show/bwclub/support18 эпизодов
Все серии
×Добро пожаловать в Player FM!
Player FM сканирует Интернет в поисках высококачественных подкастов, чтобы вы могли наслаждаться ими прямо сейчас. Это лучшее приложение для подкастов, которое работает на Android, iPhone и веб-странице. Зарегистрируйтесь, чтобы синхронизировать подписки на разных устройствах.